Back to top

Top Ranked Momentum Stocks to Buy for July 10th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 10th:

Builders FirstSource, Inc. (BLDR - Free Report) : This building materials manufacturer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.

Builders FirstSource’s shares gained 12.6% over the last one month more than S&P 500’s rise of 3.2%. The company possesses a Momentum Score of B.

CarMax, Inc. (KMX - Free Report) : This retailer of used vehicles has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.5% over the last 60 days.

CarMax’s shares gained 6.3% over the last one month. The company possesses a Momentum Score of B.

Asbury Automotive Group, Inc. (ABG - Free Report) : This automotive retailer has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.

Asbury Automotive’s shares gained 7.1% over the last one month. The company possesses a Momentum Score of A.

Walmart Inc. (WMT - Free Report) : This company that engages in the retail and wholesale operations has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.5% over the last 60 days.

Walmart'sshares gained 5% over the last one month. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>